---

Mark Paxton

Managing Director, AcceleratoRx

“Day-to-day, I am driven by the excitement that there are tremendous opportunities to improve healthcare outcomes with high quality, safe and effective drugs. Educating the various stakeholders across the globe on what this actually means is very important and there is a lot of collaborative work that still needs to be done. Currently, I am working on a couple of initiatives to accelerate the adoption of digital connectivity of drug products – especially with injectables. Such connectivity allows for healthcare providers and patients to provide significantly more specificity regarding health outcomes than is currently measured in clinical trials.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018